Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Shelton RC, Papakostas GI. Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. Objective: 

Atypical antipsychotics (AAPs) have been hypothesized to be beneficial in treatment-resistant depression (TRD). This paper will review a biochemical rationale and will summarize the data regarding the effectiveness of AAPs in TRD. Method: 

Studies were identified using searches of Pubmed/Medline, EMBase and the Cochrane databases by cross-referencing the term ‘depression’ with each of the six AAPs. Results: 

After initial positive, short case reports and clinical trials, larger studies failed to show the effectiveness of AAPs combined with antidepressants for TRD. More recently, larger scale clinical trials have supported the effectiveness of at least some of these medications. While AAPs have gained in popularity for TRD, there are nagging concerns regarding risks such as metabolic syndrome and tardive dyskinesia. Conclusion: 

The existing research provides some support for the beneficial effects of AAPs when combined with SSRI’s in TRD. These medications pose significant risks that must be considered in their use.

Keywords: antidepressants; atypical antipsychotics; augmentation; major depressive disorder; treatment resistant

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1600-0447.2007.01130.x

Affiliations: 1: Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USA 2: Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

Publication date: April 1, 2008

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more